|
Volumn 44, Issue 4, 2001, Pages 135-140
|
The effect of trimetazidine on C-reactive protein, cytokines and adhesion molecules in the course of acute myocardial infarction.
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
C REACTIVE PROTEIN;
CELL ADHESION MOLECULE;
CYTOKINE;
ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1;
INTERCELLULAR ADHESION MOLECULE 1;
INTERLEUKIN 1;
INTERLEUKIN 6;
INTERLEUKIN 8;
TRIMETAZIDINE;
TUMOR NECROSIS FACTOR ALPHA;
VASODILATOR AGENT;
ARTICLE;
BLOOD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
FEMALE;
FIBRINOLYTIC THERAPY;
HEART INFARCTION;
HUMAN;
MALE;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
RANDOMIZED CONTROLLED TRIAL;
C-REACTIVE PROTEIN;
CELL ADHESION MOLECULES;
COMBINED MODALITY THERAPY;
CYTOKINES;
DOUBLE-BLIND METHOD;
E-SELECTIN;
FEMALE;
HUMANS;
INTERCELLULAR ADHESION MOLECULE-1;
INTERLEUKIN-1;
INTERLEUKIN-6;
INTERLEUKIN-8;
MALE;
MIDDLE AGED;
MYOCARDIAL INFARCTION;
THROMBOLYTIC THERAPY;
TRIMETAZIDINE;
TUMOR NECROSIS FACTOR-ALPHA;
VASODILATOR AGENTS;
MLCS;
MLOWN;
|
EID: 0035749329
PISSN: 12114286
EISSN: None
Source Type: Journal
DOI: 10.14712/18059694.2019.100 Document Type: Article |
Times cited : (9)
|
References (0)
|